Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Short term Debt (2022 - 2025)

Exagen (XGN) has disclosed Short term Debt for 4 consecutive years, with $643000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt rose 52.01% year-over-year to $643000.0, compared with a TTM value of $643000.0 through Dec 2025, up 52.01%, and an annual FY2025 reading of $643000.0, up 52.01% over the prior year.
  • Short term Debt was $643000.0 for Q4 2025 at Exagen, down from $680000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $2.5 million in Q1 2025 and bottomed at $190000.0 in Q4 2022.
  • Average Short term Debt over 4 years is $561153.8, with a median of $423000.0 recorded in 2024.
  • The sharpest move saw Short term Debt grew 5.51% in 2024, then skyrocketed 845.9% in 2025.
  • Year by year, Short term Debt stood at $190000.0 in 2022, then soared by 38.95% to $264000.0 in 2023, then soared by 60.23% to $423000.0 in 2024, then soared by 52.01% to $643000.0 in 2025.
  • Business Quant data shows Short term Debt for XGN at $643000.0 in Q4 2025, $680000.0 in Q3 2025, and $667000.0 in Q2 2025.